Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8361)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2016 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chai NL, Zhang XB, Chen SW, Fan KX, Linghu EQ. Umbilical cord-derived mesenchymal stem cells alleviate liver fibrosis in rats. World J Gastroenterol 2016; 22(26): 6036-6048 [PMID: 27468195 DOI: 10.3748/wjg.v22.i26.6036] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i26/6036.htm |
| Number | Citing Articles |
| 1 |
Martina Colicchia, Daniel A. Jones, Anne-Marie Beirne, Mohsin Hussain, Deshan Weeraman, Krishnaraj Rathod, Jessry Veerapen, Mark Lowdell, Anthony Mathur. Umbilical cord–derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical data. Cytotherapy 2019; 21(10): 1007 doi: 10.1016/j.jcyt.2019.04.056
|
| 2 |
Pingji Liu, Lichao Yao, Xue Hu, Zheng Wang, Zhiyu Xiong, Yingan Jiang. Recent advances in the immunomodulation mechanism of mesenchymal stem cell therapy in liver diseases. Journal of Gastroenterology and Hepatology 2023; 38(7): 1099 doi: 10.1111/jgh.16247
|
| 3 |
Milad Ahani-Nahayati, Vahid Niazi, Alireza Moradi, Bahareh Pourjabbar , Reza Roozafzoon, Saeed Heidari Keshel, Alireza Baradaran-Rafii. Umbilical Cord Mesenchymal Stem/Stromal Cells Potential to Treat Organ
Disorders; An Emerging Strategy. Current Stem Cell Research & Therapy 2022; 17(2): 126 doi: 10.2174/1574888X16666210907164046
|
| 4 |
John T. Walker, Armand Keating, John E. Davies. Cell Engineering and Regeneration. 2019; : 1 doi: 10.1007/978-3-319-37076-7_10-1
|
| 5 |
John T. Walker, Armand Keating, John E. Davies. Cell Engineering and Regeneration. 2020; : 237 doi: 10.1007/978-3-319-08831-0_10
|
| 6 |
Chanbin Lee, Minju Kim, Jinsol Han, Myunghee Yoon, Youngmi Jung. Mesenchymal Stem Cells Influence Activation of Hepatic Stellate Cells, and Constitute a Promising Therapy for Liver Fibrosis. Biomedicines 2021; 9(11): 1598 doi: 10.3390/biomedicines9111598
|
| 7 |
Bing Li, Yu Cheng, Songyan Yu, Li Zang, Yaqi Yin, Jiejie Liu, Lin Zhang, Yiming Mu. Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy Ameliorates Nonalcoholic Fatty Liver Disease in Obese Type 2 Diabetic Mice. Stem Cells International 2019; 2019: 1 doi: 10.1155/2019/8628027
|
| 8 |
Marcin Michalik, Aleksandra Gładyś, Piotr Czekaj. Differentiation of Cells Isolated from Afterbirth Tissues into Hepatocyte-Like Cells and Their Potential Clinical Application in Liver Regeneration. Stem Cell Reviews and Reports 2021; 17(2): 581 doi: 10.1007/s12015-020-10045-2
|
| 9 |
Sandra Brückner, Alexander Zipprich, Madlen Hempel, Antje Thonig, Fabian Schwill, Martin Roderfeld, Elke Roeb, Bruno Christ. Improvement of portal venous pressure in cirrhotic rat livers by systemic treatment with adipose tissue–derived mesenchymal stromal cells. Cytotherapy 2017; 19(12): 1462 doi: 10.1016/j.jcyt.2017.09.006
|
| 10 |
森昊 常. Research Progress on the Role and Mechanism of Exosomes Derived from Mesenchymal Stem Cells under Hypoxic Con-ditions. Advances in Clinical Medicine 2023; 13(06): 9577 doi: 10.12677/ACM.2023.1361340
|
| 11 |
Yinzhong Ma, Lisha Wang, Shilun Yang, Dongyu Liu, Yi Zeng, Lilong Lin, Linhui Qiu, Jiahao Lu, Junlei Chang, Zhihuan Li. The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice. Stem Cell Research & Therapy 2021; 12(1) doi: 10.1186/s13287-021-02463-x
|
| 12 |
Munther Alomari. Advances in Application of Stem Cells: From Bench to Clinics. Stem Cell Biology and Regenerative Medicine 2021; 69: 123 doi: 10.1007/978-3-030-78101-9_6
|
| 13 |
Zhengqi Hu, Zhiliang Jiang, Shengzi Meng, Rong Liu, Kun Yang. Research Progress on the Osteogenesis-Related Regulatory Mechanisms of Human Umbilical Cord Mesenchymal Stem Cells. Stem Cell Reviews and Reports 2023; 19(5): 1252 doi: 10.1007/s12015-023-10521-5
|
| 14 |
Sheeba Khan, Sara Mahgoub, Nada Fallatah, Patricia F Lalor, Philip N Newsome. Liver Disease and Cell Therapy: Advances Made and Remaining Challenges. Stem Cells 2023; 41(8): 739 doi: 10.1093/stmcls/sxad029
|
| 15 |
Ye Xie, Jia Yao, Mengchao Yan, Yan Lin, Jiayun Wei, Haiping Wang, Yongcui Mao, Pinyan Liu, Xun Li. Pretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophils. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04732-0
|
| 16 |
Meixian Wu, Yuanyuan Li, Yiwei Wang, Yifan Li, Jinghui Li, Jing Xie, Shuang Zhao, Lihua Sun. HOXA10 Expressing UCMSCs Transplantation Improved Endometrial
Receptivity on Endometrial Injury. Current Stem Cell Research & Therapy 2023; 18(7): 1001 doi: 10.2174/1574888X17666220919111814
|
| 17 |
Christiane Uder, Sandra Brückner, Sandra Winkler, Hans‐Michael Tautenhahn, Bruno Christ. Mammalian MSC from selected species: Features and applications. Cytometry Part A 2018; 93(1): 32 doi: 10.1002/cyto.a.23239
|
| 18 |
Chengmei He, Yanlei Yang, Kunyu Zheng, Yiran Chen, Suying Liu, Yongzhe Li, Qin Han, Robert Chunhua Zhao, Li Wang, Fengchun Zhang. Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges. Therapeutic Advances in Chronic Disease 2021; 12 doi: 10.1177/2040622321993442
|
| 19 |
Yan-Wei Li, Chong Zhang, Qiu-Ju Sheng, Han Bai, Yang Ding, Xiao-Guang Dou. Mesenchymal stem cells rescue acute hepatic failure by polarizing M2 macrophages. World Journal of Gastroenterology 2017; 23(45): 7978-7988 doi: 10.3748/wjg.v23.i45.7978
|
| 20 |
Ya Yang, Yalei Zhao, Lingjian Zhang, Fen Zhang, Lanjuan Li. The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.655268
|
| 21 |
Fan Ding, Yuting Liu, Jia Li, Xiao Wei, Jiangdong Zhao, Xiaojing Liu, Liqiang Zhang. TC14012 enhances the anti-fibrosis effects of UC-MSCs on the liver by reducing collagen accumulation and ameliorating inflammation. Stem Cell Research & Therapy 2024; 15(1) doi: 10.1186/s13287-024-03648-w
|
| 22 |
Xiaoli Rong, Junzhi Liu, Xia Yao, Tiechao Jiang, Yimin Wang, Feng Xie. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway. Stem Cell Research & Therapy 2019; 10(1) doi: 10.1186/s13287-019-1204-2
|
| 23 |
Xiufang Wei, Guang Sun, Xiaoxue Zhao, Qianqian Wu, Ling Chen, Yichi Xu, Xining Pang, Guoxian Qi. Human amnion mesenchymal stem cells attenuate atherosclerosis by modulating macrophage function to reduce immune response. International Journal of Molecular Medicine 2019; doi: 10.3892/ijmm.2019.4286
|
| 24 |
Yulin He, Xingrong Guo, Tingyu Lan, Jianbo Xia, Jinsong Wang, Bei Li, Chunyan Peng, Yue Chen, Xiang Hu, Zhongji Meng. Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling. Stem Cell Research & Therapy 2021; 12(1) doi: 10.1186/s13287-021-02468-6
|
| 25 |
Chenxia Hu, Lingfei Zhao, Jinfeng Duan, Lanjuan Li. Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis. Journal of Cellular and Molecular Medicine 2019; 23(3): 1657 doi: 10.1111/jcmm.14115
|
| 26 |
Mengmeng Yang, Yixin Cui, Jia Song, Chen Cui, Lingshu Wang, Kai Liang, Chuan Wang, Sha Sha, Qin He, Huiqing Hu, Xinghong Guo, Nan Zang, Lei Sun, Li Chen. Mesenchymal stem cell-conditioned medium improved mitochondrial function and alleviated inflammation and apoptosis in non-alcoholic fatty liver disease by regulating SIRT1. Biochemical and Biophysical Research Communications 2021; 546: 74 doi: 10.1016/j.bbrc.2021.01.098
|
| 27 |
Da Cheng, Jin Chai, Huiwen Wang, Lei Fu, Shifang Peng, Xin Ni. Hepatic macrophages: Key players in the development and progression of liver fibrosis. Liver International 2021; 41(10): 2279 doi: 10.1111/liv.14940
|
| 28 |
Ali Mahmoudi, Pouria Meidany, Wael Almahmeed, Tannaz Jamialahmadi, Amirhossein Sahebkar. Stem Cell Therapy as a Potential Treatment of Non-Alcoholic Steatohepatitis-Related End-Stage Liver Disease: A Narrative Review. Current Stem Cell Reports 2024; 10(4): 85 doi: 10.1007/s40778-024-00241-y
|
| 29 |
Alireza Pouyandeh Ravan, Farjam Goudarzi, Hassan Rafieemehr, Mahdi Bahmani, Fariba Rad, Mohammad Jafari, Marzieh Mahmoodi. Human umbilical cord-mesenchymal stem cells conditioned medium attenuates CCl4 induced chronic liver fibrosis. Toxin Reviews 2021; 40(2): 238 doi: 10.1080/15569543.2019.1590849
|
| 30 |
I. V. Maiborodin, V. V. Morozov, A. A. Anikeev, N. F. Figurenko, R. V. Maslov, V. A. Matveeva, G. A. Chastikina, V. I. Maiborodina. Possibility of Aggravation of Tissue Sclerosis after Injection of Multipotent Mesenchymal Stromal Cells Near the Forming Cicatrix in the Experiment. Bulletin of Experimental Biology and Medicine 2017; 163(4): 554 doi: 10.1007/s10517-017-3848-1
|
| 31 |
I. V. Maiborodin, V. V. Morozov, A. A. Anikeev, R. V. Maslov, N. F. Figurenko, V. A. Matveeva, V. I. Maiborodina. Some Peculiarities of Local Distribution of Multipotent Mesenchymal Stromal Cells after Their Injection into Intact Muscle Tissue in Experiment. Bulletin of Experimental Biology and Medicine 2018; 164(4): 554 doi: 10.1007/s10517-018-4031-z
|
| 32 |
I. V. Maiborodin, A. I. Shevela, V. V. Morozov, A. A. Anikeev, N. F. Figurenko, R. V. Maslov, S. V. Homeniuk. The Specific Features of Tissue Reaction after Vein Ligation in Experiment. Flebologiia 2017; 11(3): 154 doi: 10.17116/flebo2017113154-163
|
| 33 |
Heng-Tong Han, Wei-Lin Jin, Xun Li. Mesenchymal stem cells-based therapy in liver diseases. Molecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-022-00088-x
|
| 34 |
Mengmei Zhu, Tianzhen Hua, Tao Ouyang, Huofu Qian, Bing Yu, Huseyin Sumer. Applications of Mesenchymal Stem Cells in Liver Fibrosis: Novel Strategies, Mechanisms, and Clinical Practice. Stem Cells International 2021; 2021: 1 doi: 10.1155/2021/6546780
|
| 35 |
Yinan Deng, Yingcai Zhang, Linsen Ye, Tong Zhang, Jintao Cheng, Guihua Chen, Qi Zhang, Yang Yang. Umbilical Cord-derived Mesenchymal Stem Cells Instruct Monocytes Towards an IL10-producing Phenotype by Secreting IL6 and HGF. Scientific Reports 2016; 6(1) doi: 10.1038/srep37566
|
| 36 |
Hafiz Ghufran, Maryam Azam, Azra Mehmood, Muhammad Umair, Maria T. Baig, Saba Tasneem, Hira Butt, Sheikh Riazuddin. Adipose Tissue and Umbilical Cord Tissue: Potential Sources of Mesenchymal Stem Cells for Liver Fibrosis Treatment. Journal of Clinical and Experimental Hepatology 2024; 14(4): 101364 doi: 10.1016/j.jceh.2024.101364
|
| 37 |
Sitong Yi, Qingwei Cong, Ying Zhu, Qiumin Xu, Giuseppe Mandraffino. Mechanisms of Action of Mesenchymal Stem Cells in Metabolic-Associated Fatty Liver Disease. Stem Cells International 2023; 2023: 1 doi: 10.1155/2023/3919002
|
| 38 |
Amirhossein Tamimi, Mona Javid, Nasrin Sedighi-Pirsaraei, Arian Mirdamadi. Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1420281
|